Clinical Trials · NCT03442972
Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral Lipids
- Phase
- Phase 2/Phase 3
- Recruitment status
- Completed
- Sponsor
- University Health Network, Toronto
- Enrollment
- 21
- Start date
- Jan 2019
- Locations
- 2 sites, Canada
- Primary endpoint
- Release of enteral lipids in response to teduglutide